Laura Lovett
As researchers rush for COVID-19 cure, new platform seeks to help link patients with clinical trials
The new tool called, World Without COVID, is aimed at matching potential volunteers to new clinical trials.
Patients can also get care access to gender-affirming hormone therapy, pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), urinary tract infection screening and the morning after pill with the new service.
Users will be able to use the service to tap into membership telehealth-provider PlushCare.
The company plans to use the new funds to expand commercialization in the US, Europe and Israel.
Women’s Health USA, QED Investors, LabCorp, Fool Ventures and Gore Range Capital participated in this round.
According to the new Rock Health funding report in Q1 digital health companies raised $3.1 billion in new investments. However, with the coronavirus hurting the economy, the rest of the year may not follow suit.
The new round was led by General Catalyst with participation from F-Prime Capital, Kickstart Seed Fund, Diōko Ventures and Jonathan Bush.
During a HIMSS20 webinar, Seattle Children's Hospital's Chief Data Officer Ryan Sousa explains the hospital's digital transformation.
The new MIT COVID-19 Challenge: Beat the Pandemic is a series of hackathons and digital events focused on coming up with ways to address the virus.
The new maps will be able to look at co-location, movement and social interaction data.